Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Baiza-Durán, Leopoldo
56  Ergebnisse:
Personensuche X
?
1

Glycosylation differences of an anti-VEGF monoclonal antibo..:

Quiñonez-Alvarado, Mayra G. ; Chávez-Hurtado, Paulina ; Caro-Palomera, Jesús C....
Biologicals.  84 (2023)  - p. 101711 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Pharmacokinetics and Safety of an Intravitreal Humanized An..:

Muñoz-Villegas, Patricia ; Sanchez-Rios, Alejandra ; Quinonez-Alvarado, Mayra G...
Journal of Experimental Pharmacology.  13 (2021)  - p. 545-554 , 2021
Link: https://doi.org/10.2147/..
 
?
3

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoe..:

Palacio-Pastrana, Claudia ; Chávez-Mondragón, Eduardo ; Soto-Gómez, Abraham...
Clinical Ophthalmology.  14 (2020)  - p. 1581-1589 , 2020
Link: https://doi.org/10.2147/..
 
?
4

Safety and tolerability evaluation after repeated intravitr..:

Baiza-Durán, Leopoldo ; Sánchez-Ríos, Alejandra ; González-Barón, Joel...
International Journal of Retina and Vitreous.  6 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Efficacy and Safety of Sodium Hyaluronate/chondroitin Sulfa..:

Belalcázar-Rey, Sandra ; Sánchez Huerta, Valeria ; Ochoa-Tabares, Juan C...
Current Eye Research.  46 (2020)  7 - p. 919-929 , 2020
Link: https://doi.org/10.1080/..
 
?
6

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing..:

Olvera-Montaño, Oscar ; Baiza-Duran, Leopoldo ; Quintana-Hau, Juan D...
Drug Design, Development and Therapy.  13 (2019)  - p. 3813-3821 , 2019
Link: https://doi.org/10.2147/..
 
?
7

A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0..:

Gómez-Aguayo, Francisco ; Paczka, José A. ; Leñero-Córdova, Rubén...
Ophthalmology and Therapy.  7 (2018)  1 - p. 145-156 , 2018
Link: https://doi.org/10.1007/..
 
?
8

Bioavailability of generic 0.05% difluprednate emulsion in ..:

Mercado-Sesma, Arieh ; Contreras-Rubio, Angélica ; Baiza-Durán, Leopoldo...
Journal of Ophthalmic Inflammation and Infection.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
9

Histopathological changes on the ocular surface of New Zeal..:

Contreras-Rubio, Angélica Y. ; Baiza-Durán, Leopoldo ; Olvera-Montaño, Oscar...
International Ophthalmology.  36 (2016)  6 - p. 841-844 , 2016
Link: https://doi.org/10.1007/..
 
?
10

Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsio..:

Baiza-Durán, Leopoldo M. ; Muñoz-Villegas, Patricia ; Sánchez-Ríos, Alejandra..
Journal of Ophthalmology.  2023 (2023)  - p. 1-9 , 2023
Link: https://doi.org/10.1155/..
 
?
11

Underreporting and Triggering Factors for Reporting ADRs of..:

Contreras-Salinas, Homero ; Baiza-Durán, Leopoldo Martín ; Bautista-Castro, Manuel Alejandro..
Healthcare.  10 (2022)  11 - p. 2182 , 2022
Link: https://doi.org/10.3390/..
 
?
12

Evaluation of the Rheological Properties, Preclinical Safet..:

Palacio-Pastrana, Claudia ; Muñoz-Villegas, Patricia ; Dániel-Dorantes, Fernando...
Medical Devices: Evidence and Research.  15 (2022)  - p. 293-305 , 2022
Link: https://doi.org/10.2147/..
 
?
13

Novel therapies for proliferative retinopathies:

Martinez-Alejo, Juan Manuel ; Baiza-Duran, Leopoldo Martin ; Quintana-Hau, Juan de Dios
Therapeutic Advances in Chronic Disease.  13 (2022)  - p. 204062232211403 , 2022
Link: https://doi.org/10.1177/..
 
?
14

Ocular Cyclopentolate: A Mini Review Concerning Its Benefit..:

Contreras-Salinas, Homero ; Orozco-Ceja, Vanessa ; Romero-López, María Soledad...
Clinical Ophthalmology.  16 (2022)  - p. 3753-3762 , 2022
Link: https://doi.org/10.2147/..
 
?
15

Active Pharmacovigilance in Peruvian Population: Surveillan..:

Contreras-Salinas, Homero ; Barajas-Hernández, Mariana ; Baiza-Durán, Leopoldo Martín...
Clinical Ophthalmology.  16 (2022)  - p. 245-246 , 2022
Link: https://doi.org/10.2147/..
 
1-15